Podcasts about Molecular neuroscience

The first drugs to slow Alzheimer's progression have been making headlines around the world. For researchers in the field, the arrival of these two therapies called Lecanemab and Donanemab is testament to decades of advancements in the field of Alzheimer's research because for the first time they go further than modifying the symptoms and have been shown in trials to slow down cognitive decline. For patients and families these treatments offer hope that the amount of quality time they'll have together could be lengthened. Around the world regulatory bodies are weighing up their effectiveness, safety and cost. In the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) has approved Lecanemab and Donanemab for use but the National Institute for Health and Care Excellence (NICE) rejected them for use in the NHS on the basis the benefit to patients did not outweight the cost, although they could still be available privately.Presenter James Gallagher examines the decision with Professor of Public Health Carol Brayne from the University of Cambridge and neuroscientist Professor Tara Spires-Jones from the University of Edinburgh. Then, looking forward, he meets scientists searching for future treatments including Dr Emma Mead, chief scientist at the Alzheimer's UK Drug Discovery Institute at the University of Oxford, Dr Ashvini Keshavan, co-lead of University College London's ADAPT blood biomarker trial, Selina Wray, Professor of Molecular Neuroscience and Alzheimer's Research UK Senior Research Fellow at University College London, and UK Dementia Research Institute Emerging Leader Dr Claire Durrant.This programme was produced in partnership with The Open University.Presenter: James Gallagher Producer: Tom Bonnett Editor: Holly Squire

Heute spreche ich mit Dr. Henning Beck. Er ist ein anerkannter Neurowissenschaftler mit einem tiefen Verständnis für Biochemie und Neurowissenschaften, erworben durch sein Studium in Tübingen und seine Promotion an der Graduate School of Cellular & Molecular Neuroscience. Nach seiner akademischen Laufbahn erweiterte er sein Wissen mit einem Projektmanagement-Diplom in Berkeley und unterstützte Start-Ups in der San Francisco Bay Area, innovative Denkweisen zu entwickeln. Henning ist bekannt für seine Fähigkeit, komplexe neurowissenschaftliche Inhalte verständlich und unterhaltsam zu vermitteln, was er in Vorträgen, Seminaren und Büchern unter Beweis stellt. In seinen Werken, wie dem jüngsten Buch „12 Gesetze der Dummheit“, erforscht er, warum Menschen trotz besseren Wissens fehlerhafte Entscheidungen treffen, und plädiert für ein rationaleres Denken zur Vermeidung gesellschaftlicher Missstände. Get in Touch mit Henning: https://www.henning-beck.com Mein Podcast bei Spotify & Co: https://podcasters.spotify.com/pod/show/daniel-jung Get in Touch with me: https://danieljung.io #Neurowissenschaften #Lernen #Podcast #danieljungpodcast #HenningBeck

Kerris Bright, Chief Customer Officer at the BBC, started her marketing career after completing her PhD in Molecular Neuroscience which set her in great stead. The combination of science and creativity has been crucial throughout her marketing career. Kerris has the desire to become a leader that listens more and has the ability to recognise potential in more people, despite already becoming a very genuine honest, caring leader. She is very honest and mentions that her biggest regret is not recognising potential sooner. Kerris refers to her three C's; curiosity, clarity and certainty, as pillars to support her as she takes on each challenge. She is a naturally curious person that is passionate about understanding how people work and how things work demonstrating that her background in science and transition to marketing may not be so random after all. Topics: Curiosity, certainty, clarity Life at the BBC Recognising potential Leadership Transitioning from science to marketing Sponsored by School of Marketing.

On episode 133 Dr. James Vanlandingham talks about how his work as a physiotherapist and his severe traumatic brain injury led him to a doctorate in Molecular Neuroscience and then post-doc work in Behavioural Neuroscience, and how all of this led him to his idea for the treatment of acute brain injury.Check out my store at Tee Public!Get there from concussiontalk.com, Concussion Talk's Merch tab on Podchaser, or on Tee Public; shirts, hoodies, masks, notebooks, mugs, stickers and a whole bunch of other stuff! Support my podcast and help spread brain injury awareness! Thank you! Get bonus content on PatreonSupport this show http://supporter.acast.com/concussion-talk-podcast. Hosted on Acast. See acast.com/privacy for more information.

This is Episode 71 of the Dr. Finance® Live Podcast hosted by Dr. Anthony M. Criniti IV (aka “Dr. Finance®”). Dr. Criniti interviewed Brett Favre, NFL Hall of Fame quarterback and football legend, concussion expert, leader, & speaker. Dr. Criniti also interviewed Dr. Jacob W. VanLandingham, molecular neuroscientist, entrepreneur, speaker, & survivor. NFL legend Brett Favre attended the University of Southern Mississippi, and after a stellar college career, Favre was selected by the Atlanta Falcons in the 1991 NFL draft. Following his trade to the Green Bay Packers the next year, Favre began his legendary NFL career and led the franchise to victory in Super Bowl XXXI. Favre, an NFL ironman, started 299 consecutive games, a record that still stands today. Among his achievements, he recorded six 4,000 passing yard seasons, was named all NFC six times, and elected to eleven Pro Bowl teams. When Favre retired from football after the 2010 season, he held the NFL record for passing attempts, completions, passing yards, and touchdown passes. Favre was enshrined into the NFL Hall of Fame in 2016. Dr. Jacob W. VanLandingham is Odyssey's Head of Drug Development. Dr. VanLandingham has a Ph.D. in Molecular Neuroscience from Florida State University. His postdoctoral training was in Behavioral Neuroscience within the Emergency Medicine Department at Emory University, where he served as the Assistant Lab Director for the Brain Research Lab in the Department of Emergency Medicine. Dr. VanLandingham has over 20 years of research experience in brain injury and neurosteroid and enantiomer mechanisms of action. Prior to his Ph.D. work, he was a Physical Therapist and cared for brain-injured children for three years. Dr. VanLandingham was one of the Year 1-2 Course Directors for nine years at the Florida State University College of Medicine. He has been honored with multiple teaching, grant and patent awards. He has overseen his own clinic for treating concussed patients and developed rehab techniques to improve return to activity. In 2012, Dr. VanLandingham began developing the first drug to treat concussion acutely. Odyssey acquired the technology, and Dr. VanLandingham was brought on to lead the R&D efforts. Dr. Anthony M. Criniti IV (aka “Dr. Finance®”) is the world's leading financial scientist and survivalist. A fifth generation native of Philadelphia, Dr. Criniti is a former finance professor at several universities, a former financial planner, an active investor in diverse marketplaces, an explorer, an international keynote speaker, and has traveled around the world studying various aspects of finance. He is an award winning author of three #1 international best-selling finance books: The Necessity of Finance (2013), The Most Important Lessons in Economics and Finance (2014), and The Survival of the Richest (2016). As a prolific writer, he also frequently contributes articles to Entrepreneur, Medium, and Thrive Global. Dr. Criniti has started a grassroots movement that is changing the way that we think about economics and finance. For more information about Doctor Finance, please visit https://DrFinance.Info. Disclaimer: This Podcast is for informational purposes only. It is presented with the understanding that the author(s) and the publisher(s) are not engaged in providing financial, legal, or other professional services. If financial, legal, or any other form of advice is needed, please consult a financial advisor, an attorney, or another professional advice-giving entity. 

Technical difficulties so the first Afterparty! that was supposed to be live was actually re-scheduled and then we ended up doing it w/ just us on Zoom. So here it is! Listen to us recap this week's episode, talk about how it landed for us and share what YOU had to say in the poll results this week! Get To Know Steven Steven Westbrook is a Certified Strength and Conditioning Specialist + Clinical Exercise Physiologist. He also recently became a 500HR Yoga Alliance Instructor. He holds degrees in Cellular & Molecular Neuroscience, Cognitive Psychology and has a Masters degree in biochemistry. . You can catch his classes online and locally! Connect with him here!

Welcome to the new format! . AND an educational conversation where Steven breaks down the science of what it means to flourish and we introduce some concepts to support you in flourishing in your own life. . We also share our personal insights and we had some fun too! . Listen in and continue the conversation in the comments! . And as a reminder, with this new format we still want to hear what you think- only this time you have some time to listen and apply what we share! . Head to Instagram and give us a follow (linked below) because on Wednesday of this week (June 29, 2022) I will be posting polls to see how what we shared in this episode is showing up in your life! . Then join us LIVE on Friday July 1 for The Afterparty! at noon eastern where we will recap the episode, share what you had to say this week and live coach! . See you then!! . Get To Know Steven . Steven Westbrook is a Certified Strength and Conditioning Specialist + Clinical Exercise Physiologist. He also recently became a 500HR Yoga Alliance Instructor. He holds degrees in Cellular & Molecular Neuroscience, Cognitive Psychology and has a Masters degree in biochemistry. . You can catch his classes online and locally! Connect with him here!

This week we will be learning about bipolar disorder! It's a condition characterized by extreme mood swings from emotional highs to emotional lows. One week someone may end up sleeping 24 hours straight and the next week go on a $10,000 gambling spree in Vegas. Are you curious about the neural activity and neurotransmitters involved in these sudden shifts in mood? Come and take a listen to Episode 20!Please rate, review, and subscribe and if you have any questions, comments, concerns, queries, or complaints, please email me at neuroscienceamateurhour@gmail.com or DM me at NeuroscienceAmateurHour on Instagram.Citations below:Bipolar disorder - Symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/bipolar-disorder/symptoms-causes/syc-20355955#:~:text=OverviewNational Alliance on Mental Illness. Bipolar disorder | NAMI: National Alliance on Mental Illness. nami.org. Published August 2017. https://www.nami.org/About-Mental-Illness/Mental-Health-Conditions/Bipolar-DisorderHow Is Bipolar Disorder Diagnosed? WebMD. Accessed May 17, 2022. https://www.webmd.com/bipolar-disorder/guide/bipolar-disorder-diagnosis#091e9c5e800091a5-1-1Craddock N, Jones I. Genetics of bipolar disorder. Journal of Medical Genetics. 1999;36(8):585-594. doi:10.1136/jmg.36.8.585Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience. 2009;164(1):331-343. doi:10.1016/j.neuroscience.2009.03.080Ahmed NY, Knowles R, Dehorter N. New Insights Into Cholinergic Neuron Diversity. Frontiers in Molecular Neuroscience. 2019;12. doi:10.3389/fnmol.2019.00204van Enkhuizen J, Janowsky DS, Olivier B, et al. The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited. European journal of pharmacology. 2015;753:114-126. doi:10.1016/j.ejphar.2014.05.063Keck PE, McElroy SL, Arnold LM. BIPOLAR DISORDER. Medical Clinics of North America. 2001;85(3):645-661. doi:10.1016/s0025-7125(05)70334-5Machado-Vieira R, Manji HK, Zarate Jr CA. The Role of Lithium in the Treatment of Bipolar disorder: Convergent Evidence for Neurotrophic Effects as a Unifying Hypothesis. Bipolar Disorders. 2009;11:92-109. doi:10.1111/j.1399-5618.2009.00714.xMalhi GS, Tanious M, Das P, Coulston CM, Berk M. Potential Mechanisms of Action of Lithium in Bipolar Disorder. CNS Drugs. 2013;27(2):135-153. doi:10.1007/s40263-013-0039-0Support the show

Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: A Brief Excursion Into Molecular Neuroscience, published by Jan on April 10, 2022 on LessWrong. TL;DR: Poking fun at complicated nomenclature (p̴͓̂͘á̴̻͌s̶̻̗͋͑ṯ̸̹̈́̌à̶̳), identifying a pretty important signaling factor in the brain, and arbitrating (part of) the Guzey/Mendonça debate. Previously in this series: How to build a mind - neuroscience edition. The Emperor's New Ǫ̵͎͊G̶̦̉̇l̶͉͇̝̽͆̚i̷͔̓̏͌c̷̱̙̍̂͜k̷̠͍͌l̷̢̍͗̃n̷̖͇̏̆å̴̤c̵̲̼̫͑̎̆ (Ǫ̵͎͊G̶̦̉̇l̶͉͇̝̽͆̚i̷͔̓̏͌c̷̱̙̍̂͜k̷̠͍͌l̷̢̍͗̃n̷̖͇̏̆å̴̤c̵̲̼̫͑̎̆ is an intentionally garbled version of the word O-GlcNAc. The reasons for garbling it will hopefully become clear while reading this essay!) Flashback: It's June 7th, 2017. The transformer architecture will drop on the arxiv in 5 days, Hugh Hefner will die in less than 3 months, and the computational neuroscience community is having a field day on Twitter. It started with this tweet from Michael Nitabach from Yale School of Medicine complaining about opaque jargon in theoretical papers: There was a bit of goofy back and forth about the (un)importance of mathematical vocabulary in neuroscience, some attempts at explaining the term, and eventually the call for a workshop on "Manifold-splaining", which happened half a year later. There are some things to be said here about how we use terminology or what manifolds actually are, but I'm bringing this up because I distinctly remember an offhand comment that someone made at that workshop. The comment was that it's unfair that experimentalists get to write things like "O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination," and nobody gives them hell for writing their papers in Klingon. Or at least they are not getting enough hell for it. When I was first confronted with the alphabet soup that calls itself molecular neuroscience, I was awed by my colleagues, who appeared to be fluent in speaking p̴͓̂͘á̴̻͌s̶̻̗͋͑ṯ̸̹̈́̌à̶̳. It took me a year or two to figure out that they also do not know what most of the terms mean - and for most abbreviations, there are only a handful of people in the world who can decode them. But nobody likes to acknowledge that they don't know what things mean publicly. Therefore everybody nods along when they read Ǫ̵͎͊G̶̦̉̇l̶͉͇̝̽͆̚i̷͔̓̏͌c̷̱̙̍̂͜k̷̠͍͌l̷̢̍͗̃n̷̖͇̏̆å̴̤c̵̲̼̫͑̎̆. So it's fine if you don't know what it means. Almost nobody does. Let's talk about BDNF. Perhaps you are the kind of person that takes the preceding paragraphs as a challenge, and you'd like to learn to speak p̴͓̂͘á̴̻͌s̶̻̗͋͑ṯ̸̹̈́̌à̶̳ yourself. Or perhaps you like to read about different levels of abstraction, what we gain by using them, and how we can transition between them. Or perhaps you're having a slow day and want to learn something funky. In all those cases, this essay is certainly for you. But perhaps you are a very busy person, and you tend to be very selective about how you spend your time. Perhaps you want to be sure that if you're going to dive into this mess of molecules, you'll be able to get a Pareto-sized chunk of insight in return. Perhaps you've been hurt before and have difficulties trusting any molecule. In all those cases, this section is here to assuage you. Let me motivate why you might care about the protagonist of this essay, the "brain-derived neurotrophic factor" (BDNF). Argument from interestingness. BDNF has shown up repeatedly in the rationality-sphere over the last years: Alexey Guzey's thesis about why you shouldn't sleep circles around BDNF. Natália Mendonça's counter-thesis that you should sleep all the time attacks Guzey's claims about BDNF. Scott Alexander explained a few years ago how an increase in BDNF plays a central role in the function of antidepressants. Then there was a big Cell paper that argued for the importance of the canonical BDNF receptor (TrkB) rather than BDNF....

Link to original articleWelcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: A Brief Excursion Into Molecular Neuroscience, published by Jan on April 10, 2022 on LessWrong. TL;DR: Poking fun at complicated nomenclature (p̴͓̂͘á̴̻͌s̶̻̗͋͑ṯ̸̹̈́̌à̶̳), identifying a pretty important signaling factor in the brain, and arbitrating (part of) the Guzey/Mendonça debate. Previously in this series: How to build a mind - neuroscience edition. The Emperor's New Ǫ̵͎͊G̶̦̉̇l̶͉͇̝̽͆̚i̷͔̓̏͌c̷̱̙̍̂͜k̷̠͍͌l̷̢̍͗̃n̷̖͇̏̆å̴̤c̵̲̼̫͑̎̆ (Ǫ̵͎͊G̶̦̉̇l̶͉͇̝̽͆̚i̷͔̓̏͌c̷̱̙̍̂͜k̷̠͍͌l̷̢̍͗̃n̷̖͇̏̆å̴̤c̵̲̼̫͑̎̆ is an intentionally garbled version of the word O-GlcNAc. The reasons for garbling it will hopefully become clear while reading this essay!) Flashback: It's June 7th, 2017. The transformer architecture will drop on the arxiv in 5 days, Hugh Hefner will die in less than 3 months, and the computational neuroscience community is having a field day on Twitter. It started with this tweet from Michael Nitabach from Yale School of Medicine complaining about opaque jargon in theoretical papers: There was a bit of goofy back and forth about the (un)importance of mathematical vocabulary in neuroscience, some attempts at explaining the term, and eventually the call for a workshop on "Manifold-splaining", which happened half a year later. There are some things to be said here about how we use terminology or what manifolds actually are, but I'm bringing this up because I distinctly remember an offhand comment that someone made at that workshop. The comment was that it's unfair that experimentalists get to write things like "O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination," and nobody gives them hell for writing their papers in Klingon. Or at least they are not getting enough hell for it. When I was first confronted with the alphabet soup that calls itself molecular neuroscience, I was awed by my colleagues, who appeared to be fluent in speaking p̴͓̂͘á̴̻͌s̶̻̗͋͑ṯ̸̹̈́̌à̶̳. It took me a year or two to figure out that they also do not know what most of the terms mean - and for most abbreviations, there are only a handful of people in the world who can decode them. But nobody likes to acknowledge that they don't know what things mean publicly. Therefore everybody nods along when they read Ǫ̵͎͊G̶̦̉̇l̶͉͇̝̽͆̚i̷͔̓̏͌c̷̱̙̍̂͜k̷̠͍͌l̷̢̍͗̃n̷̖͇̏̆å̴̤c̵̲̼̫͑̎̆. So it's fine if you don't know what it means. Almost nobody does. Let's talk about BDNF. Perhaps you are the kind of person that takes the preceding paragraphs as a challenge, and you'd like to learn to speak p̴͓̂͘á̴̻͌s̶̻̗͋͑ṯ̸̹̈́̌à̶̳ yourself. Or perhaps you like to read about different levels of abstraction, what we gain by using them, and how we can transition between them. Or perhaps you're having a slow day and want to learn something funky. In all those cases, this essay is certainly for you. But perhaps you are a very busy person, and you tend to be very selective about how you spend your time. Perhaps you want to be sure that if you're going to dive into this mess of molecules, you'll be able to get a Pareto-sized chunk of insight in return. Perhaps you've been hurt before and have difficulties trusting any molecule. In all those cases, this section is here to assuage you. Let me motivate why you might care about the protagonist of this essay, the "brain-derived neurotrophic factor" (BDNF). Argument from interestingness. BDNF has shown up repeatedly in the rationality-sphere over the last years: Alexey Guzey's thesis about why you shouldn't sleep circles around BDNF. Natália Mendonça's counter-thesis that you should sleep all the time attacks Guzey's claims about BDNF. Scott Alexander explained a few years ago how an increase in BDNF plays a central role in the function of antidepressants. Then there was a big Cell paper that argued for the importance of the canonical BDNF receptor (TrkB) rather than BDNF....

Carmen graduated from Florida Atlantic University's Honors College in 2019 with a double major in Biology and Molecular Neuroscience. She began veterinary school the following Fall and officially joined Dr. Adam Moeser's lab in January 2022. Her research primarily focuses on the role of androgens and the effects of neonatal castration on functional development of the gastrointestinal immune system. In her free time Carmen enjoys cooking, going to the gym, and flying down to visit family in Florida. To keep up to date with WaMPS updates, you can follow @msuwamps on Instagram, Twitter, Facebook, or visit our website https://www.wamps.org. If you would like to learn more about graduate school in physics and astronomy at MSU, check out https://pa.msu.edu If you would like to leave comments, questions, or recommend someone to be interviewed on Journeys of Scientists, you can email WaMPS outreach coordinator Bryan at stanl142@msu.edu

The bacteria in your gut can talk to your brain.No, really.It might sound like science fiction, but you've probably heard the phrase ‘gut-brain axis' used in recent years to describe this phenomenon. What we call the “gut” actually refers to the small and large intestines, where a collection of microorganisms known as the gut microbiome reside. In addition to the microbes that inhabit it, your gut contains around 500 million neurons, which connect to your brain through bidirectional nerves – the biggest of which is the vagus nerve. Bacteria might be able to interact with specialized sensory cells within the gut lining and trigger neuronal firing from the gut to the brain. Our guest this week is Caroline Hernández, a PhD student in the Maude David Lab in the Department of Microbiology, and she is studying exactly this phenomenon.Hosted by Grace Deitzler & Miriam LiptonCheck out the ID Blog: https://blogs.oregonstate.edu/inspiration/2022/02/26/trusting-your-gut-lessons-in-molecular-neuroscience-and-mental-health/

Join host Peter Beaudoin as he explores the growing health sector with Chris Bladen, CEO and Co-founder of Zymedyne Therapeutics, a Calgary based company that is developing more effective treatments for chronic pain. For the transcription of this episode please visit: https://www.rainforestab.ca/yyc-blog/podcast-episode-158-transcription Thank you for listening to the Leaders, Innovators and Big Ideas podcast, supported by Rainforest Alberta. The podcast that highlights those people who are contributing to and/or supporting the innovation ecosystem in Alberta. Host: Peter Beaudoin Peter manages strategy and partnerships for an innovative alliance of energy companies committed to reducing environmental impacts through collaborative R&D efforts. Peter worked for more than 20 years in Asia building and investing in a variety of businesses. His most recent role outside of Canada was with the World Wildlife Fund, where he was the Chief Executive Officer of WWF China, based in Beijing. Prior to that, Peter lived in Hong Kong for 15 years working in the technology industry. Guest: Dr. Chris Bladen received his PhD in Molecular Neuroscience from the Hotchkiss Brain Institute, University of Calgary in 2014. His thesis was based on using Electrophysiology and Molecular Biology to develop drugs and small molecules for Pain and Epilepsy research as well as other clinical purposes. He has a B.Sc. in Freshwater Chemistry and a degree in Environmental management and has extensive experience in both academia and industry. His previous work experience includes several years as an independent environmental consultant for the oil and gas industry in Alberta and several years working in the biopharma industry.  He has developed a world-wide collaborative network in the fields of Electrophysiology, Molecular Biology and Drug design. In addition to being CEO of Zymedyne therapeutics, he is currently an (Online) Lecturer at Macquarie University's Department of Biomedical Sciences, where he teaches Pharmacology and conducts research into the therapeutic potential of Synthetic and Phyto Cannabinoids. Please be sure to share this episode with everyone you know. If you are interested in being either a host, a guest, or a sponsor of the show, please reach out. We are published in Google Podcasts and the iTunes store for Apple Podcasts We would be grateful if you could give us a rating as it helps spread the word about the show. Show Quotes: "[Big Pharma] see smaller biopharma companies, such as ourselves as being much more nimble in the R and D space. So they look to partner with multiple small biopharma and their ideas, and then take some of those ideas and they do what they they're good at, which is the latest stage clinical trial planning phases. And of course the FDA approval marketing." Credits... This Episode Sponsored By: Assembly Coworking Space Episode Music: Tony Del Degan Creator & Producer: Al Del Degan  

How can zebrafish lead to new insight into how neurons within the brain function? Researchers may be able to determine how information is sent between the two by studying the specific relationships between their retinas and brains. Listen up to learn: How neurons connect How long visual information takes to be processed Why ocular tissue is challenging to study in humans Tom Baden, Professor of Neuroscience at the University of Sussex, shares his research into how the body sends input information for the brain to process. By examining large numbers of nerve cells and how they respond to specific stimuli, researchers can determine how inputs cause the brain to react. From information from the retina and showing how different colors are sent, the information pathway can be tracked. Tissue from the retina of humans is surprisingly very similar to the tissue found in non-human primates. From studying humans going forward in research, the determination that similar principles hold between the two. This is currently one of the driving factors behind new information is found.  For more information, visit https://badenlab.org. Episode also available on Apple Podcasts: apple.co/30PvU9C

Mental health is just as important as physical health. It’s not just a concept of being weak but rather, it is a concept of psychological and emotional well-being that needs to be in the spotlight more for people to better understand it. The stigma surrounding mental illness keeps people from getting the help they need to get better and causes them to hide their pain. Today many individuals including students face mental health crises because of academic pressure, peer or family problems, and even because of the pandemic. That is why in this episode, Dr. Gabiola and her co-host, Ms. Alyssa, were joined by eight students - brilliant minds who shared their insights and thoughts about mental health awareness and their personal experiences about this matter.Learn from these amazing students about the importance of mental health awareness, different coping mechanisms, and strategies that you can apply, do’s and don’t whenever you are experiencing anxiety and depression, ways on how to break the stigma of mental health, and what you can do as an individual.Jump right in to listen to this episode and remember that mental illness should not be something to be ashamed about or thought of differently. YOU are important, YOU are loved, and YOU got this!Memorable Quotes:Since May 2020, on average, more than one in three adults in the United States has reported symptoms of anxiety and or a depressive disorder, compared to only one in ten adults reporting the same symptoms from before the pandemic in January to June of 2019. - Alyssa SalesOne of the most important tools with mental health is having a support system. - EvanThe mental health of resident physicians is really important because future doctors are just constantly stressed by this pandemic. - John SoyLeaders want to see change, but you also can take it within yourself to see what you can do and how you can be that change. - Jamie AlbertsonThere's a cultural barrier to addressing mental health. - John SoySelf-isolation really impacts relationships with your friends and family. It's not combating issues, not combating anxiety, it's not combating depression because it's only enhancing it and feeding it. - John SoyHaving a diary is really helpful because you can rant and let all of the thoughts that are in your head and write them out on paper. While is more of you take these thoughts and then you can categorize them into different thoughts and bring more awareness to it and being more mindful with it. - John SoyBeing able to realize where you are with your own mental health and then finding something to be an outlet to help you grow and to help you come out of your own thought. - John Soy Emotions are normal. Sadness is normal. Anxiety is normal. - John SoyOne of the main stigmas of mental health is that it is a weakness. - Kate WilliamsEvery person wants someone to speak out, remind them that they can see themselves in. - Kate WilliamsContinuing on this cycle of creating this pressure and creating a very unhealthy environment where mental health, depression, anxiety, suicidal ideation can just grow because of the way the students see themselves to make academic success. - Kate WilliamsAbout the Guest/s:Alyssa Sales, the co-host for today’s episode, is a sophomore at Columbia University whose multiracial background drives her to improve resources for the underserved and marginalized people through a dialogue on culture and tradition, and mental health.Kate is a senior in high school and the president of ROCN, Reach Out Care Now, a mental health organization. She’s also the wellness commissioner for the student executive council. Danette Navalo or “Kata” is currently a sophomore attending Columbia University, majoring in Political Science and Ethnicity and Race studies. She creates social content that focuses on indigenous identity with a special emphasis on lifting other indigenous creators. Evan is a junior high school leader of the KUTO club, or Kids Under Twenty One, which deals with mental health awareness. John Soy is a resident physician at Stanford Hospital. He got his master's degree in Molecular Neuroscience at Johns Hopkins, and currently, he is studying Psychiatry. Jamie Albertson is a student educator and activist in the Bay area. And Sophia is a junior at Lynbrook High School and she’s part of Lynbrook Alafia, a student outreach publication that serves as a safe place for students to anonymously share their stories with the community.About the Host:Dr. Jette is a Clinical Professor of Medicine at Stanford University and the President & CEO of ABCs for Global Health. Click here for her full profile or read her full interview here.Click here for the FULL TRANSCRIPT. See acast.com/privacy for privacy and opt-out information.

In this episode, I chat with Prof. Marina Picciotto, the Charles B. G. Murphy Professor of Psychiatry and Professor in the Child Study Center, and the Departments of Neuroscience and of Pharmacology, and the Deputy Director, Kavli Institute for Neuroscience at Yale University. Prof. Picciotto completed a postdoctoral fellowship with Jean-Pierre Changeux in the Laboratory of Molecular Neuroscience at the Institut Pasteur in Paris and earned a Ph.D. in Molecular Neurobiology in the Laboratory of Molecular and Cellular Neuroscience at Rockefeller University under Paul Greengard, a future Nobel Laureate. Prof. Picciotto is a pioneering neuroscientist known for her groundbreaking work on the role of nicotine in addiction, memory, and reward behaviors. She's also the current Editor-in-Chief of The Journal of Neuroscience, the field's trademark journal. We talk about her very interesting journey through science, exploring the intricacies and conducting phenomenal research in neuroscience, her terrific mentorship and influence on the field leading a prestigious journal through the era of preprints and digitization, and many more things!!

Can building houses that allow humans to live on Mars be the key to sustaining life on our planet? The need for sustainable housing has never been greater and not for interplanetary colonisation, but for supporting human life through climate change happening on our planet. In this conversation with Dr Natalie Rens, we explore how her work in creating sustainable houses for the new colonies being planned for the red planet could be the key to preserving life on our beautiful blue one. Dr Natalie Rens is a neuroscientist, artificial intelligence strategist, and space nerd. Natalie is the founder and CEO of Astreia, a startup building autonomous habitats for a sustainable future. Prior, she worked as the Artificial Intelligence Specialist for the Office of the Queensland Chief Entrepreneur, implementing strategies to advance AI capability in Queensland. She also built Queensland AI, an AI meetup with over 2,500 members. Natalie holds a PhD in Neuroscience, Master in Cellular and Molecular Neuroscience, and a Bachelor in Biomedical Science (honours). Natalie now works and lives in Austin, Texas in the USA. She plans to live on Mars next. Learn more about Dr Natalie Rens on LinkedIn - https://www.linkedin.com/in/dr-natalie-rens/ Visit Astreia's site here - https://astreia.com/ Learn more about my work in Narrative Strategy at www.spendloveandlamb.com or visit www.storiescreate.me for more information on this podcast. Listen on iTunes - podcasts.apple.com/au/podcast/stor…1437980600?mt=2 Stitcher - www.stitcher.com/podcast/megan-da…te-me?refid=stpr Google Play -play.google.com/music/listen?t=St…kgety3kpxjqezhaja

Dr. Fang Liu is a Senior Scientist and Head of Molecular Neuroscience in the Campbell Family Mental Health Research Institute at CAMH. Dr. Liu and Kelsi discuss Dr. Liu's research, discoveries, how changes in the brain can affect trauma victims, and how new discoveries can be used to help prevent PTSD. Watch on YouTube: https://bit.ly/3opNURn - - - - - - - - - - - - - SUPPORT OUR SPONSORS Heads up Guys - https://headsupguys.org Jackson Rowe - 15% off with code UNITY - https://jacksonrowe.ca Combat Flip Flops - 25% off with code UNITY - https://combatflipflops.com BN3TH - 15% off with code UNITY - https://bn3th.com - - - - - - - - - - - - - SHOP B&U Jewelry & Eyewear: https://brassandunity.com - - - - - - - - - - - - - Follow #brassandunity IG: https://instagram.com/brassandunity FB: https://facebook.com/brassandunity - - - - - - - - - - - - - Follow Kelsi IG: https://instagram.com/kelsie_sheren

Dr. Liu joins me to discuss how peptides in the brain can help prevent PTSD. BIO: Dr. Fang Liu, a Senior Scientist & Head of Molecular Neuroscience in CAMH’s Campbell Family Mental Health Research Institute; Professor & Co-director of Division of Neuroscience & Clinical Translation, Department of Psychiatry at the University of TorontoResearch led by Dr. Liu points to a groundbreaking discovery about a new potential treatment and prevention for post-traumatic stress disorder (PTSD). The research team, led by Dr. Fang Liu, discovered and developed peptides that could prevent recall or encoding of fear memories which suggests that the peptide could treat PTSD symptoms or prevent them entirely. This is a completely new approach to PTSD and for psychiatric disorders in general.PTSD occurs in some people after experiencing or witnessing traumatic events, such as sexual assault or military combat. Patients can suffer from debilitating flashbacks, nightmares and anxiety which can severely impact quality of life. There are currently no laboratory diagnostic tests for PTSD, and existing treatments have limited efficacy. If you want go from feeling hopeless to hopeful, lonely to connected and like a burden to a blessing, then go to 1-on-1 coaching, go to www.thrivewithleo.com. Let’s get to tomorrow, together. National Suicide Prevention Lifeline800-273-TALK [800-273-8255]1-800-SUICIDE [800-784-2433]Teen Line (Los Angeles)800-852-8336The Trevor Project (LGBTQ Youth Hotline)866-488-7386National Domestic Violence Hotline800-799-SAFE [800-799-7233]Crisis Text LineText "Connect" to 741741 in the USALifeline Chathttps://suicidepreventionlifeline.org/chat/International Suicide Resources: https://www.iasp.info/resources/Crisis_Centres/

This KGI Industry Talk features Ravneesh Sachdev, the Vice President and Head of Business Development at Sage Therapeutics, based in Cambridge, MA. Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, including Zulresso™, the first FDA-approved drug specifically for postpartum depression. Ravneesh evaluates and transacts on partnerships in order to inorganically grow Sage’s business. Over the past 15+ years of his business development career, Ravneesh has contributed to, as well as led, the execution of more than 20 partnerships during his tenure at several other companies, namely Pfizer, Onyx Pharmaceuticals (now part of Amgen), UCB Pharma, Acorda Therapeutics, and Bioverativ (now part of Sanofi). Ravneesh earned his bachelor’s degree in Molecular Neuroscience from Claremont McKenna College, his Master of Business and Science degree from KGI, and his MBA in Healthcare Leadership from Yale University School of Management. 

Dr. Jessica Barnes is the CEO & Co-founder of the 20Lighter Program, a ground breaking scientifically based obesity intervention. She has a passion for health, female entrepreneurship, and helping others be their best. She is an alumnus of Worcester Polytechnic Institute, and earned her PhD in Molecular Neuroscience from the University of Illinois at Urbana-Champaign. She was a fellow in the department of pediatric neuro-oncology at the Dana-Farber Cancer Institute and Children's Hospital Boston under the mentorship of Dr. Judah Folkman. Her previous roles have included Director of New Ventures at Access BridgeGap Ventures, Senior Science Officer at Summer Street Research Partners, and Vice President in MEDACorp at Leerink Swann. Additionally, she provides Business & Corporate Development consulting services to biotech & medical device companies. Fun Fact: Dr. Barnes is training for her first Triathlon.Dr. Dembrowski received his doctorate from Palmer College of Chiropractic West. With a deep 20+ year background in private practice and primary patient care he brings extensive integrative patient care experience along with holistic health expertise to the 20Lighter team.

Dr. Jessica Barnes / 20Lighter Dr. Jessica Barnes is the CEO & Co-founder of the 20Lighter Program, a ground breaking scientifically based obesity intervention. She has a passion for health, female entrepreneurship, and helping others be their best. She is an alumnus of Worcester Polytechnic Institute, and earned her PhD in Molecular Neuroscience from the […]

Remember that time you forgot your own phone number? Or how about that time you messed up a simple math equation? In Scatterbrain, neuroscientist Henning Beck explains why perfectionism is pointless — and argues that mistakes, missteps, and flaws are the keys to success. A PhD graduate from the Graduate School of Cellular & Molecular Neuroscience, … Continue reading Henning Beck: “The brain is the last and greatest mystery in science” →

Prof. Matthew Nolan leads a systems neuroscience laboratory at the University of Edinburgh. His research focuses on the molecular and circuit mechanisms underlying memory and navigation in the hippocampal – entorhinal system. Prof. Nolan is a rare example of a scientist whose work appeals both to pure theoreticians and hard line experimentalists. In this episode, we discuss –> open science and the value of reviewer anonymity –> the concept of “cell type” and its (mis)use in the navigation field –> how to supervise long-term projects and guide them to completion

In a lecture at Rancho Springs Medical Center, Murrieta, California, Dr. Eric Madrid discusses intermittent Fasting (IF) and the Ketogenic Diet and its beneficial effects in the treatment of diabetes, high cholesterol and more. Dr. Madrid discusses common health myths such as one must eat 3 meals per day and breakfast is the most important meal of the day. Dr. Madrid shares the history of fasting, intermittent fasting and how incorporating fasting into one’s life can have significant benefits.  He explains the 12:12 plan, 16:8 plan, 18: 6 and 23:1 plans. He also explains how he now will vary his eating schedule from day to day.  He will eat using a 12:12, 18:6, 23:1, 16:8, etc. Dr. Madrid also discusses the ketogenic diet and its ability to help reduce weight and ultimately blood sugar and cholesterol levels.  Recommended Books:  The Obesity Code by Dr. Jason Fung Keto-tarian by Dr. Will Cole Recommended website for keto recipes:  www.ketoconnect.net Follow Dr. Madrid on Social Media: Facebook.com/ericmadridmd Instagram @ericmadridmd Twitter @ericmadridmd Search "Eric Madrid" on Youtube References: Woolf, Eric C., Nelofer Syed, and Adrienne C. Scheck. “Tumor Metabolism, the Ketogenic Diet and Β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy.” Frontiers in Molecular Neuroscience 9 (2016): 122. PMC. Web. 25 Jan. 2017 Cheng C-W, Adams GB, Perin L, et al. Prolonged Fasting reduces IGF-1/PKA to promote hematopoietic stem cell-based regeneration and reverse immunosuppression. Cell stem cell. 2014;14(6):810-823. doi:10.1016/j.stem.2014.04.014. Fasting increases longevity in Laboratory rats  https://www.sciencedirect.com/science/article/pii/S0047637400001093 Cancer and Neurological Diseaese  Eur J Clin Invest. 2016 Mar;46(3):285-98.  Increased lifespan in mice- Cell Metab. 2017 Sep 5;26(3):539-546.e5. doi: 10.1016/j.cmet.2017.08.005. Migraines and Keto Neurol Sci. 2017 May;38(Suppl 1):111-115.  Pediatric use of Keto diet Pediatr Ann. 2016 Dec 1;45(12):e446-e450. Autism Improves withKeto Metab Brain Dis. 2017 Dec;32(6):1935-1941 

I’m a fairly hopeful guy. Sure, I have dark moments as we all do but, hope wins out more often than not. You might be wondering how I can have hope or be hopeful while dealing with an incurable, progressive brain disease like Parkinson’s. It’s a fair question. I don’t know that I have the answers, but in this episode I go about searching for a better understanding of the role that hope plays in the Parkinson’s community. What I discover is that hope is the one driving force that binds us all together. No matter if you are a person with Parkinson’s, a caregiver, a nurse, neurologist, physiotherapist, counselor, general practitioner or a support group leader we are all dealing in hope. Dr. Matt Farrer is a Professor of Medical Genetics and Molecular Neuroscience at Pacific Parkinson’s Research Centre at the University of British Columbia. He is agenetic researcher who hopes his work will eradicate Parkinson’s. Last year, he mapped my genome and is set to reveal the results of those tests in this episode of the podcast. I also talk to Wendy Edey, a facilitator of Hope at “Hope Studies Central” at the University of Alberta, who has studied the impacts of hope as it relates to Parkinson’s disease. She says, “When you have hope you have the capacity to think about the future and be okay.” Someone who embodies the power of hope in my eyes is the Reverend Dixie Black. The Deacon of Christ Church Cathedral in Vancouver has been living with a Parkinson’s diagnosis since 2013. “Hope means to me trust. Trust that however it goes, I’m not alone and I’ll be taken care of.” In the episode we talk about hope as a common denominator to science and spirituality, we explore the concept of hope, where to find hope, how to keep it and the role it plays in the living our best lives despite the Parkinson’s diagnosis.   I hope you listen.   Follow me, Larry Gifford  Twitter: @ParkinsonsPod Facebook: Facebook.com/ParkinsonsPod Instagram: @parkinsonspod Follow Co-host and Producer Niki Reitmeyer Twitter: @Niki_Reitmayer Thank you toDrMatt Farrer and the staff at the Djavad Mowafaghian Centre for Brain Health https://www.centreforbrainhealth.ca/. Follow the Centre for Brain Health on Twitter at @DMCBrainHealth.  Wendy Edey, Facilitor of Hope at “Hope Studies Central” https://sites.google.com/a/ualberta.ca/hope-studies/home Reverend Dixie Black, Deacon of Christ Church Cathedral in Vancouver. Read and listen to her sermons here. And special thanks to my wife Rebecca Gifford. For more info on our partner Parkinson Canada head to http://www.parkinson.ca/ The toll free hotline is 1-800-565-3000 Or follow them on Twitter Parkinson Canada            @ParkinsonCanada Parkinson Society BC      @ParkinsonsBC Credits Dila Velazquez – Story Producer Rob Johnston – Senior Audio Producer

Hindsight suffuses our working life, perhaps none more so than in research. Being as it is a process of discovery and learning of things we didn’t know. As such in many ways there will always be things we wish we’d known earlier.  Today we would like to discuss whether the investigative process brings with it complexities and uncertainties that are universal, and can therefore be shared with others as a means to avoid similar pitfalls - as our panel explore 'Things they wish they had known sooner'. In the chair we have Dr Amy Monaghan from the Alzheimer’s Research Drug Discovery Unit at University College London. Amy is joined by Dr Deborah Oliviera from the University of Nottingham, Hanna Isotalus from University of Bristol and Dr Mark Dallas a Lecturer in Cellular and Molecular Neuroscience at the University of Reading.

Today on the show we interview Professor Anthony Holtmaat who is currently Leena’s Principal Investigator or her supervisor. Anthony received his Masters in Science in Medical Biology and his PhD in Molecular Neuroscience from Utrecht University in the Netherlands. He is currently a full professor and has his own laboratory at the University of Geneva in Switzerland. We talked about everything from growing up in the Netherlands to using a process known as synaptic plasticity to reorganize working brain circuits, to compensate for damaged brain circuits. This type of work could for example improve recovery after a stroke.

Dr. Randy Blakely is a Professor of Biomedical Science at Florida Atlantic University and Executive Director of the Florida Atlantic University Brain Institute. Randy lives in beautiful South Florida near the Everglades, so getting outside to enjoy nature and observe the local wildlife is a lot of fun there. He also spends his time reading, listening to audiobooks during his commutes, and listening to Americana and folk music. In the lab, Randy studies how chemicals in the brain called neurotransmitters work. He is examining how neurons control neurotransmitter signaling, as well as how medicinal drugs and drugs of abuse impact neurotransmitters and ultimately behavior. Randy received his B.A. in Philosophy from Emory University and his Ph.D. in Neuroscience from the Johns Hopkins School of Medicine. He next conducted postdoctoral research at the Yale/Howard Hughes Medical Institute Center for Molecular Neuroscience. Randy was an investigator and faculty member at Emory University and Vanderbilt university before accepting his current position at Florida Atlantic University. Randy is the recipient of numerous awards and honors for his research and mentorship. He was awarded the Daniel Efron Award from the American College of Neuropsychopharmacology, two Distinguished Investigator Awards from the Brain and Behavioral Research Foundation, a MERIT Award from the National Institute of Mental Health, a Zenith Award from the Alzheimer’s Association, the Delores C. Shockley Partnership Award in recognition of minority trainee mentorship, as well as the Astellas Award in Translational Pharmacology and the Julius Axelrod Award both from the American Society for Pharmacology and Experimental Therapeutics. In addition, he is a Fellow of the American Academy for the Advancement of Science. Randy joins us in this episode to talk more about his life and science.

This week’s Radio COTA Podcast # 68 features the final episode in our two part series, “Focus on Dementia” Having looked into what exactly Dementia is, how it can affect a person, their friends and their families, and how we can adjust our nutritional focus to help minimise the effects, in Part 2 we look at the importance of focused exercise in the fight against Dementia, and the valuable ground-breaking research going on behind the scenes in this area. Our special Guest this week is the Queensland Brain Institute’s Professor Perry Bartlett, Professor in Molecular Neuroscience at the University of Queensland Professor Bartlett breaks down the science into user-friendly plain English, helping us all to gain a better insight into a disease that has either directly or indirectly touched us all. So, make yourself a cuppa, put your feet up, and enjoy all that Radio COTA brings to you .. Please send us your feedback and suggestions, we'd love to hear from you ... Email us at ... radiocota@cotaqld.org.au Enjoy the show ! Your host, Andy Neil

Show description/summary:1) Intracerebral hemorrhage location and outcome among clinical trial participants 2) What's Trending: childhood amnesiaThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the April 11, 2017 issue of Neurology. In the first segment, Dr. Andrew Schomer talks with Dr. Craig Anderson about his paper on intracerebral hemorrhage location and outcome among clinical trial participants. Then, for our “What's Trending” feature of the week, Dr. Ted Burns talks with Dr. Cristina Alberini about her paper on childhood amnesia. Disclosures can be found at Neurology.org.DISCLOSURES: Dr. Anderson served on scientific advisory boards for Astra Zeneca and Medtronic; receives honoraria and travel funding from Takeda China and Boehringer Ingelheim; serves on editorial boards for Stroke, Cerebrovascular Diseases, and International Journal of Stroke; and receives research support from the National Medical Research Council of Australia (grants 1052555, 1020462, and 1081356).Dr. Alberini serves on editorial boards for Neural Plasticity, Journal of Cell Science, Frontiers in Neuroscience, Neurobiology of Learning and Memory, Behavioral Neuroscience, Learning and Memory, European Brain Research Institute (EBRI) International Scientific Council (ISC), and Cellular and Molecular Neuroscience of Hippocampus. Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc. All other participants report no disclosures.

We speak with Jernej Ule, Professor of Molecular Neuroscience at University College London about an RNA-binding protein called Nova, switching from one good project to another great one, and linking a love of art to science,

A few weeks ago, Anthony and Chad attended a meetup.com event for an atheist group. We wanted to break down our experience and encourage you all to reach out to a similar group; especially if you have to conceal your beliefs for any reason. Also, Anthony joined the Freedom From Religion Foundation to further reach out to the secular community, and he tells you about the benefits of doing so. Let us know what you think, and enjoy!   Twitter: @SecularPodcast @Obsessiveviewer @Obsessivechad   Email: TheSecularPerspective@gmail.com   Facebook: facebook.com/thesecularperspective   Tumblr: http://thesecularperspective.tumblr.com/   Episode Index Website: TheSecularPerspective.com   Theme Music Provided By: http://www.jewelbeat.com/   PLEASE CLICK HERE TO DONATE TO CHAD'S CHARITY! Or, plug this link into your internet search window: https://www.extra-life.org/index.cfm?fuseaction=donate.start&destination=P&eventID=520&participantID=93945 Tags: Secularism, Atheism, Agnosticism, Humanism, Antitheism, Religion, Belief, Faith, God, Children's Miracle Network, meetup.com, Atheists Etcetera, New Atheism, Richard Dawkins, Chicago, Quakers, Africa, Underground Railroad, IUPUI, Molecular Neuroscience, Eli Lilly, University of Iowa, Statistics, Criminal Justice, Ivy Tech Community College, Wellpoint, Hobby Lobby, Fort Wayne Indiana, Freedom From Religion Foundation, Town of Greece v. Galloway, Facebook, Hell, Pope Francis, Catholicism, Parochial School, Reddit, Memes

Hank Thompson is a comedian and producer at The Young Turks (youtube.com/TYTComedy), and his brother Dr. Chris Thompson is a post-doctoral fellow at Scripps Research Institute in the Department of Cellular and Molecular Neuroscience. This powerful comedy/science sibling duo join Matt and Andy this week to discuss: Sibling rivalry! Vocal communication in animals! Learned vocalization! Dolphins who know their own names! Inverted commas! Everything you ever wanted to know about songbirds! Chicago ladies! 3D syrinx models! Burning out parts of bird brains! Terrible Hunger Games writing! Taxi drivers' enlarged hippocampi! Axons, neurons, dendrites and synapses! The effect of Prozac on birds' songs! Getting harrassed by amateur birders! Albino African clawed frogs! Inheriting the chess team captain crown! Andy's upcoming 1,000-mile road trip with a Belgian stranger! The Jimmy Dore Show on TYT Comedy!

1) Spinal ischemic stroke and 2) Topic of the month: Child neurology topics. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Pearce Korb interviews Dr. Ronen Leker about his paper on spinal ischemic stroke following dialysis. Dr. Chafic Karam is reading our e-Pearl of the week about adrenomyeloneuropathy. In the next part of the podcast Dr. Jeff Waugh interviews Dr. Jonathan Mink about the topic of pediatric movement disorders. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Leker, Karam and Mink.Dr. Leker serves as an editorial board member of Journal of Molecular Neuroscience, Current Neurovascular Research and Journal of the Israeli Neurological Association.Dr. Karam served on the editorial team for the Neurology® Resident and Fellow Section. Dr. Mink serves as an Associate Editor for Neurology®; serves as an editorial board member of Journal of Child Neurology and Pediatric Neurology; serves on the scientific advisory board for Edison Pharmaceuticals Inc. and Data and Safety Monitoring Board; and receives research support from the NIH.

Guest: Randy Blakely, PhD Host: Vatsal Thakkar, MD Dopamine is an important neurotransmitter in the cortex, essential to movement and activity control, as well as attention and executive function, tying this transporter to ADHD. How are scientists finding the genetic markers that may be transmitted to those with ADHD, and how does this help scientists understand more about the disorder? Dr. Randy Blakely, director of the Center for Molecular Neuroscience at the Silvio O. Conte Center for Neuroscience Research and the Alan D. Bass Professor of Pharmacology and Psychiatry at the Vanderbilt University School of Medicine, describes a genetic mutation that causes the dopamine transporter to run backwards, and how this discovery is helping scientists understand the mechanisms of ADHD. Dr. Vatsal Thakkar hosts.

Guest: Randy Blakely, PhD Host: Vatsal Thakkar, MD Dopamine is an important neurotransmitter in the cortex, essential to movement and activity control, as well as attention and executive function, tying this transporter to ADHD. How are scientists finding the genetic markers that may be transmitted to those with ADHD, and how does this help scientists understand more about the disorder? Dr. Randy Blakely, director of the Center for Molecular Neuroscience at the Silvio O. Conte Center for Neuroscience Research and the Alan D. Bass Professor of Pharmacology and Psychiatry at the Vanderbilt University School of Medicine, describes a genetic mutation that causes the dopamine transporter to run backwards, and how this discovery is helping scientists understand the mechanisms of ADHD. Dr. Vatsal Thakkar hosts.